Novo Biosciences' Grant

Novo Biosciences raised a round of funding on September 07, 2017. Investors include National Institutes of Health.

Novo Biosciences is a regenerative medicine company developing small molecule therapies that reactivate and stimulate innate healing abilities in humans and animals. Its most recent lead molecule, ZF1…

Articles about Novo Biosciences' Grant: